Co-immunization with two recombinant Eimeria tenella lines expressing immunoprotective antigens of E. maxima elicits enhanced protection against E. maxima infection

Abstract Background Live anticoccidial vaccines have been a tremendous success for disease prevention. The establishment of the reverse genetic manipulation platform has enabled the development of Eimeria parasites, the live anticoccidial vaccine strains, as vaccine vectors. In our previous study, r...

Full description

Bibliographic Details
Main Authors: Xinming Tang, Chaoyue Wang, Lin Liang, Dandan Hu, Sixin Zhang, Chunhui Duan, Jingxia Suo, Xianyong Liu, Xun Suo, Shangjin Cui
Format: Article
Language:English
Published: BMC 2019-07-01
Series:Parasites & Vectors
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13071-019-3605-6
_version_ 1819229045098807296
author Xinming Tang
Chaoyue Wang
Lin Liang
Dandan Hu
Sixin Zhang
Chunhui Duan
Jingxia Suo
Xianyong Liu
Xun Suo
Shangjin Cui
author_facet Xinming Tang
Chaoyue Wang
Lin Liang
Dandan Hu
Sixin Zhang
Chunhui Duan
Jingxia Suo
Xianyong Liu
Xun Suo
Shangjin Cui
author_sort Xinming Tang
collection DOAJ
description Abstract Background Live anticoccidial vaccines have been a tremendous success for disease prevention. The establishment of the reverse genetic manipulation platform has enabled the development of Eimeria parasites, the live anticoccidial vaccine strains, as vaccine vectors. In our previous study, recombinant E. tenella expressing a single immunodominant antigen of E. maxima (Et-EmIMP1) was able to protect chickens against challenge infection with E. maxima. This promising result encouraged us to further explore strategies to improve the protection efficacy of recombinant Eimeria and develop it as a vaccine vector. Results We constructed a novel recombinant Eimeria line expressing apical membrane antigen 1 of E. maxima (Et-EmAMA1) and then immunized chickens with Et-EmAMA1 and/or Et-EmIMP1. We found that the E. maxima soluble antigen-specific cell-mediated immunity was much stronger in the birds that were co-immunized with Et-EmAMA1 and Et-EmIMP1 than in those that were immunized with Et-EmAMA1 or Et-EmIMP1 alone. The oocyst production after E. maxima infection was significantly reduced in the recombinant Eimeria-immunized birds compared with the wild-type-immunized and naïve birds. The oocyst production in the birds co-immunized with Et-EmAMA1 and Et-EmIMP1 was consistently the lowest among the treatment groups after E. maxima infection. Conclusions These results demonstrated that Eimeria is an effective vaccine vector that can carry and deliver heterologous Eimeria antigens to the host immune system and trigger specific immune responses. Our results also suggested that increasing the number of recombinant Eimeria lines is an effective approach to enhance protective immunity against infections with heterologous pathogens.
first_indexed 2024-12-23T11:06:55Z
format Article
id doaj.art-3896e36d594542869b8321614596c5b4
institution Directory Open Access Journal
issn 1756-3305
language English
last_indexed 2024-12-23T11:06:55Z
publishDate 2019-07-01
publisher BMC
record_format Article
series Parasites & Vectors
spelling doaj.art-3896e36d594542869b8321614596c5b42022-12-21T17:49:28ZengBMCParasites & Vectors1756-33052019-07-011211810.1186/s13071-019-3605-6Co-immunization with two recombinant Eimeria tenella lines expressing immunoprotective antigens of E. maxima elicits enhanced protection against E. maxima infectionXinming Tang0Chaoyue Wang1Lin Liang2Dandan Hu3Sixin Zhang4Chunhui Duan5Jingxia Suo6Xianyong Liu7Xun Suo8Shangjin Cui9Institute of Animal Science, Chinese Academy of Agricultural SciencesKey Laboratory of Zoonosis of Ministry of Agriculture & National Animal Protozoa Laboratory, College of Veterinary Medicine, China Agricultural UniversityInstitute of Animal Science, Chinese Academy of Agricultural SciencesKey Laboratory of Zoonosis of Ministry of Agriculture & National Animal Protozoa Laboratory, College of Veterinary Medicine, China Agricultural UniversityKey Laboratory of Zoonosis of Ministry of Agriculture & National Animal Protozoa Laboratory, College of Veterinary Medicine, China Agricultural UniversityKey Laboratory of Zoonosis of Ministry of Agriculture & National Animal Protozoa Laboratory, College of Veterinary Medicine, China Agricultural UniversityKey Laboratory of Zoonosis of Ministry of Agriculture & National Animal Protozoa Laboratory, College of Veterinary Medicine, China Agricultural UniversityKey Laboratory of Zoonosis of Ministry of Agriculture & National Animal Protozoa Laboratory, College of Veterinary Medicine, China Agricultural UniversityKey Laboratory of Zoonosis of Ministry of Agriculture & National Animal Protozoa Laboratory, College of Veterinary Medicine, China Agricultural UniversityInstitute of Animal Science, Chinese Academy of Agricultural SciencesAbstract Background Live anticoccidial vaccines have been a tremendous success for disease prevention. The establishment of the reverse genetic manipulation platform has enabled the development of Eimeria parasites, the live anticoccidial vaccine strains, as vaccine vectors. In our previous study, recombinant E. tenella expressing a single immunodominant antigen of E. maxima (Et-EmIMP1) was able to protect chickens against challenge infection with E. maxima. This promising result encouraged us to further explore strategies to improve the protection efficacy of recombinant Eimeria and develop it as a vaccine vector. Results We constructed a novel recombinant Eimeria line expressing apical membrane antigen 1 of E. maxima (Et-EmAMA1) and then immunized chickens with Et-EmAMA1 and/or Et-EmIMP1. We found that the E. maxima soluble antigen-specific cell-mediated immunity was much stronger in the birds that were co-immunized with Et-EmAMA1 and Et-EmIMP1 than in those that were immunized with Et-EmAMA1 or Et-EmIMP1 alone. The oocyst production after E. maxima infection was significantly reduced in the recombinant Eimeria-immunized birds compared with the wild-type-immunized and naïve birds. The oocyst production in the birds co-immunized with Et-EmAMA1 and Et-EmIMP1 was consistently the lowest among the treatment groups after E. maxima infection. Conclusions These results demonstrated that Eimeria is an effective vaccine vector that can carry and deliver heterologous Eimeria antigens to the host immune system and trigger specific immune responses. Our results also suggested that increasing the number of recombinant Eimeria lines is an effective approach to enhance protective immunity against infections with heterologous pathogens.http://link.springer.com/article/10.1186/s13071-019-3605-6Recombinant EimeriaVaccine vectorApical membrane antigen 1Immune mapped protein 1Immune responses
spellingShingle Xinming Tang
Chaoyue Wang
Lin Liang
Dandan Hu
Sixin Zhang
Chunhui Duan
Jingxia Suo
Xianyong Liu
Xun Suo
Shangjin Cui
Co-immunization with two recombinant Eimeria tenella lines expressing immunoprotective antigens of E. maxima elicits enhanced protection against E. maxima infection
Parasites & Vectors
Recombinant Eimeria
Vaccine vector
Apical membrane antigen 1
Immune mapped protein 1
Immune responses
title Co-immunization with two recombinant Eimeria tenella lines expressing immunoprotective antigens of E. maxima elicits enhanced protection against E. maxima infection
title_full Co-immunization with two recombinant Eimeria tenella lines expressing immunoprotective antigens of E. maxima elicits enhanced protection against E. maxima infection
title_fullStr Co-immunization with two recombinant Eimeria tenella lines expressing immunoprotective antigens of E. maxima elicits enhanced protection against E. maxima infection
title_full_unstemmed Co-immunization with two recombinant Eimeria tenella lines expressing immunoprotective antigens of E. maxima elicits enhanced protection against E. maxima infection
title_short Co-immunization with two recombinant Eimeria tenella lines expressing immunoprotective antigens of E. maxima elicits enhanced protection against E. maxima infection
title_sort co immunization with two recombinant eimeria tenella lines expressing immunoprotective antigens of e maxima elicits enhanced protection against e maxima infection
topic Recombinant Eimeria
Vaccine vector
Apical membrane antigen 1
Immune mapped protein 1
Immune responses
url http://link.springer.com/article/10.1186/s13071-019-3605-6
work_keys_str_mv AT xinmingtang coimmunizationwithtworecombinanteimeriatenellalinesexpressingimmunoprotectiveantigensofemaximaelicitsenhancedprotectionagainstemaximainfection
AT chaoyuewang coimmunizationwithtworecombinanteimeriatenellalinesexpressingimmunoprotectiveantigensofemaximaelicitsenhancedprotectionagainstemaximainfection
AT linliang coimmunizationwithtworecombinanteimeriatenellalinesexpressingimmunoprotectiveantigensofemaximaelicitsenhancedprotectionagainstemaximainfection
AT dandanhu coimmunizationwithtworecombinanteimeriatenellalinesexpressingimmunoprotectiveantigensofemaximaelicitsenhancedprotectionagainstemaximainfection
AT sixinzhang coimmunizationwithtworecombinanteimeriatenellalinesexpressingimmunoprotectiveantigensofemaximaelicitsenhancedprotectionagainstemaximainfection
AT chunhuiduan coimmunizationwithtworecombinanteimeriatenellalinesexpressingimmunoprotectiveantigensofemaximaelicitsenhancedprotectionagainstemaximainfection
AT jingxiasuo coimmunizationwithtworecombinanteimeriatenellalinesexpressingimmunoprotectiveantigensofemaximaelicitsenhancedprotectionagainstemaximainfection
AT xianyongliu coimmunizationwithtworecombinanteimeriatenellalinesexpressingimmunoprotectiveantigensofemaximaelicitsenhancedprotectionagainstemaximainfection
AT xunsuo coimmunizationwithtworecombinanteimeriatenellalinesexpressingimmunoprotectiveantigensofemaximaelicitsenhancedprotectionagainstemaximainfection
AT shangjincui coimmunizationwithtworecombinanteimeriatenellalinesexpressingimmunoprotectiveantigensofemaximaelicitsenhancedprotectionagainstemaximainfection